Search jobs 04-May-2021 Vaccine Delivery Devices Market Will Accelerate Rapidly with Excellent CAGR in Future with top prominent players in this market
All the stats, data, facts and figures collected to structure the universal
Vaccine Delivery Devices Market report are obtained from the trustworthy sources such as websites, journals, mergers, newspapers and other authentic sources. It is a comprehensive and proficient report that focuses on primary and secondary market drivers, market share, leading segments and geographical analysis. The market share of major competitors on global level is studied where key areas such as Europe, North America, Asia Pacific and South America are taken into account in the XYZ research report. It also provides better market insights to them with which they can drive the business into right direction.
Share this article
Share this article
EXTON, Pa., April 29, 2021 /PRNewswire/ West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2021 and updated full-year 2021 financial guidance.
First-Quarter 2021 Summary (comparisons to prior-year period)
Net sales of $670.7 million grew 36.5%; organic sales growth was 31.1%.
Reported-diluted EPS of $1.99 increased 101%.
Adjusted-diluted EPS of $2.05 increased 103%.
The Company is raising full-year 2021 net sales guidance to a new range of $2.630 billion to $2.655 billion, compared to a prior range of $2.500 billion to $2.525 billion. The Company is raising full-year 2021 adjusted-diluted EPS guidance to a new range of $6.95 to $7.10, compared to a prior range of $6.00 to $6.15. Adjusted-diluted EPS and organic sales growth are Non-U.S. GAAP measurements. See discussion under the heading Non-U.S. GAAP Financial Measures in this release.
West Pharmaceutical: Q1 Earnings Snapshot apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Injectable Drug Delivery Industry Analysis and 2021 Future Trends
infinityApril 24, 2021
Injectable Drug Delivery Market Size, Share, Trends, Latest Innovations, Drivers, Dynamics And Strategic Analysis 2021-2027
Infinity Business Insights offers global and regional Injectable Drug Delivery Market insights, as well as an in-depth analysis of the market’s overall growth prospects. It also offers information about the entire business strategies of the Injectable Drug Delivery market. Furthermore, a dashboard summary of leading firms contains their effective marketing policy, business contribution.
Major industry Players:
Gerresheimer AG (Germany, Europe), BD (New Jersey, U.S), Insulet Corporation (Massachusetts, U.S), Ypsomed AG (Switzerland, Europe), SHL Medical AG (Switzerland, Europe), Eli Lilly and Company (Indiana, U.S), West Pharmaceutical Services, Inc. (Pennsylvania, U.S), Elcam Medical (Israel, Middle East), Pfizer Inc. (New York, U.S)
Print
The $50 million expansion project at West Pharmaceutical’s site in Kinston, N.C., is expected to add up to 100 new jobs.
KINSTON, N.C. As a manufacturer of drug packaging and delivery components, 2020 was a year of change and growth for the West Pharmaceutical Services Inc. site in Kinston, powered in part by increased demand from the pandemic.
That demand has placed further emphasis on a two-year, $50 million capital investment that will be made to expand production capacity at the North Carolina site.
The square footage of this expansion will be determined in the months ahead, following the completion of the project s design phase. This expansion is expected to be completed by the end of 2022.